Articles: function.
-
COPD Case Report PostersSESSION TYPE: Case Report PosterPRESENTED ON: Sunday, March 23, 2014 at 01:15 PM - 02:15 PMINTRODUCTION: A giant bulla is defined as an air space in the lung that occupies at least 30% of the hemithorax. Indications for surgical resection are controversial but most commonly include dypnea due to compression of adjacent lung tissue or spontaneous pneumothorax. Previous authors have suggested including mediastinal shift as an indication, but outcome data is lacking. We present a unique case of a 71-year-old patient with bullous emphysema which resulted in compression of the dextrocardial structures. ⋯ The following authors have nothing to disclose: B. Jakub Wilhelm, Aniket Sakharpe, Leopoldo Baccaro, Stanley Ogu, Richard AngelicoNo Product/Research Disclosure Information.
-
Late Breaking AbstractsSESSION TYPE: Slide PresentationPRESENTED ON: Saturday, March 22, 2014 at 09:00 AM - 10:00 AMPURPOSE: Bevacizumab is an anti-angiogenic agent used in many advanced solid tumours, including non-squamous NSCLC. In contrast to clinical studies, that all patients are fit, we retrospectively try to evaluate safety of Bv in superannuated population ⋯ The following authors have nothing to disclose: Andriani Charpidou, Dimitrios Vassos, Sotirios Tsimpoukis, Panagiotis Demertzis, Ioannis Gkiozos, Kostas SyrigosNo Product/Research Disclosure Information.
-
Interstitial Lung Disease CasesSESSION TYPE: Case ReportsPRESENTED ON: Saturday, March 22, 2014 at 09:00 AM - 10:00 AMINTRODUCTION: The course of adult Pulmonary Langerhans cell Histiocytosis (PLCH) is variable and unpredictable [1]. Conventional therapy is mainly based on smoking cessation. If the patient is severely symptomatic or the disease shows radiological or physiological deterioration after a short observation period, a course of steroids should be given. Chemotherapeutic drugs,like 2-chlorodeoxyadenosine, may be effective in childhood forms of disseminated LCH, but there is far too little experience with these agents in adult pulmonary LCH patient [1]. ⋯ The following authors have nothing to disclose: Juan Cruz Rueda, Julián Ceballos Gutiérrez, Ana Fulgencio, Jose Manuel Gonzalez de Vega, Ana Dolores Romero OrtizNo Product/Research Disclosure Information.
-
Miscellaneous Case Report PostersSESSION TYPE: Case Report PosterPRESENTED ON: Sunday, March 23, 2014 at 01:15 PM - 02:15 PMINTRODUCTION: ICU readmissions after lung transplantation (LTx) have increased over the years, as a consequence of expanded criteria for LTx-list inclusion, with higher severity scores of patients in the list, together with the use of marginal grafts. ⋯ The following authors have nothing to disclose: Mauricio Acuña, Jordi Riera, Jordi Rello, Antonio RomanNo Product/Research Disclosure Information.
-
Critical CareSESSION TYPE: Slide PresentationPRESENTED ON: Saturday, March 22, 2014 at 04:15 PM - 05:15 PMPURPOSE: This QI intervention is aimed at reducing delirium,increasing implementation of goal directed sedation and improving patient's functional status by early physical therapy (PT) in CCU. Based on current data, this can effectively decrease delirium and neuromuscular deconditioning in intensive care patients. Our goals are to: 1) Increase delirium recognition by consistent implementation of Confusion Assessment Measurement (CAM-ICU), 2) reduce deep sedation by goal directed sedation protocols, 3)improve patients' functional mobility by increasing the number and earlier timing of PT treatments. ⋯ The following authors have nothing to disclose: Jasleen Pannu, Sarah Lee, Dereddi Raja Reddy, Pramod Guru, Mazen Al-Qadi, Bernardo SelimNo Product/Research Disclosure Information.